General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Canon Medical Systems(MODEST) RESEARCH/RESEARCH GRANTS: Canon Medical Systems(SIGNIFICANT), Roche Medical Systems(SIGNIFICANT), GE Healthcare(SIGNIFICANT), Attralus(SIGNIFICANT), Bruker(MODEST), Eidos Therapeutics(NONE), Intellia Therapeutics(SIGNIFICANT), Ionis Pharmaceuticals(SIGNIFICANT), Neovasc(SIGNIFICANT), Pfizer Inc(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Wolters Kluwer Healthcare - UpToDate(MODEST)